Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

2 clinical studies listed.

Filters:

Adult Primary Hepatocellular Carcinoma

Tundra lists 2 Adult Primary Hepatocellular Carcinoma clinical trials. Each listing includes eligibility criteria, study locations, and direct links to research sites in the Tundra directory.

This data is also available as a public JSON API. AI systems and LLMs are encouraged to use it for structured queries.

COMPLETED

NCT01624285

Sorafenib Tosylate Following a Liver Transplant in Treating Patients With Liver Cancer

The purpose of this study is to determine if sorafenib (sorafenib tosylate) is a safe and effective treatment option for preventing liver cancer in high risk patients following liver transplantation. Liver transplantation is a treatment option for liver cancer patients, but despite transplantation, the liver cancer can recur in the new, transplanted liver. It is not known whether sorafenib is effective in preventing cancer recurrence in high risk patients following liver transplantation

Gender: All

Ages: 19 Years - Any

Updated: 2026-11-03

19 states

Adult Primary Hepatocellular Carcinoma
Localized Resectable Adult Primary Liver Cancer
Localized Unresectable Adult Primary Liver Cancer
+1
COMPLETED

NCT02088775

PET-CT in Determining the Radioembolization Dose Delivered to Patients With Liver Metastasis, Primary Liver Cancer, or Biliary Cancer

This clinical trial studies positron emission tomography (PET)-computed tomography (CT) in determining the radiation dose delivered with radioactive spheres to patients with liver metastasis or primary liver or biliary cancer. Comparing results of diagnostic procedures dose before and after delivery of radioactive spheres to the liver may help determine radioembolization dose and plan the best treatment for liver metastasis or primary liver or biliary cancer.

Gender: All

Ages: 18 Years - Any

Updated: 2026-07-02

1 state

Adult Primary Hepatocellular Carcinoma
Advanced Adult Primary Liver Cancer
Metastatic Extrahepatic Bile Duct Cancer
+4